Condensed Consolidated Balance Sheets (unaudited) - USD ($) $ in Millions	Jun. 30, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 1,722	$ 1,718
Accounts receivable, net of allowances of $128 in 2023 and $114 in 2022	2,495	2,571
Inventories	2,897	2,679
Prepaid expenses and other current assets	858	857
Current assets of discontinued operations	233	186
Total current assets	8,205	8,011
Property, plant and equipment, net	4,494	4,695
Goodwill	6,418	6,452
Other intangible assets, net	6,470	6,793
Operating lease right-of-use assets	533	541
Other non-current assets	1,067	1,109
Non-current assets of discontinued operations	698	686
Total assets	27,885	28,287
Current liabilities:
Short-term debt	249	299
Current maturities of long-term debt and finance lease obligations	1,928	1,105
Accounts payable	1,240	1,110
Accrued expenses and other current liabilities	2,278	2,170
Current liabilities of discontinued operations	70	61
Total current liabilities	5,765	4,745
Long-term debt and finance lease obligations, less current portion	14,306	15,232
Operating lease liabilities	438	447
Other non-current liabilities	1,622	1,848
Non-current liabilities of discontinued operations	123	120
Total liabilities	22,254	22,392
Commitments and contingencies
Equity:
Common stock, $1 par value, authorized 2,000,000,000 shares, issued 683,494,944 shares in 2023 and 2022	683	683
Common stock in treasury, at cost, 177,125,182 shares in 2023 and 179,062,594 shares in 2022	(11,296)	(11,389)
Additional contributed capital	6,341	6,322
Retained earnings	13,655	14,050
Accumulated other comprehensive income (loss)	(3,814)	(3,833)
Total Baxter stockholders’ equity	5,569	5,833
Noncontrolling interests	62	62
Total equity	5,631	5,895
Total liabilities and equity	$ 27,885	$ 28,287